Article Details
Retrieved on: 2024-02-29 16:24:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
AbCellera partners with Canadian governments to invest in biopharma, focusing on drug development and clinical trials for antibody drugs, which will enhance Canada's infrastructure for combating diseases like COVID-19 and create jobs.
Article found on: www.bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here